Clinical Trials Directory

Trials / Completed

CompletedNCT00974987

Boron Neutron Capture Therapy, Radiation Therapy, and Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma Multiforme

A Phase II, Multicenter, Study for Newly Diagnosed Glioblastomas Using Boron Neutron Capture Therapy, Additional X-ray Treatment and Chemotherapy

Status
Completed
Phase
Phase 2
Study type
Interventional
Enrollment
32 (actual)
Sponsor
Translational Research Center for Medical Innovation, Kobe, Hyogo, Japan · Academic / Other
Sex
All
Age
15 Years – 75 Years
Healthy volunteers
Not accepted

Summary

RATIONALE: Boron neutron capture therapy and radiation therapy use high-energy x-rays and other types of radiation to kill tumor cells. Drugs used in chemotherapy, such as temozolomide, work in different ways to stop the growth of tumor cells, either by killing the cells or by stopping them from dividing. Giving boron neutron capture therapy followed by radiation therapy and temozolomide may kill more tumor cells. PURPOSE: This phase II trial is studying the side effects of giving boron neutron capture therapy together with radiation therapy and temozolomide in treating patients with newly diagnosed glioblastoma multiforme.

Detailed description

OBJECTIVES: * Evaluate the overall survival of patients with newly diagnosed glioblastoma multiforme treated with boron neutron capture therapy, radiotherapy, and concurrent and adjuvant temozolomide. * Evaluate tumor response in patients treated with this regimen. * Evaluate the adverse effects of this regimen in these patients. OUTLINE: This is a multicenter study. Patients undergo boron neutron capture therapy followed by radiotherapy and concurrent and adjuvant oral temozolomide.

Conditions

Interventions

TypeNameDescription
RADIATIONBNCT(boron neutron capture therapy)BSH(sodium borocaptate) 100mg/kg iv for one hour starting 13 hours before irradiation, and BPA(p-boronophenylalanine) 500/mg/kg iv at a speed of 200mg/kg/hr for 2 hours starting 2 hours before irradiation. During irradiation, BPA iv continues at a speed of 100mg/kg/hr.
RADIATIONXRT(X-ray radiation treatment)After BNCT, 2Gy irradiation every day for 12 days.
DRUGTMZ(temozolomide)75mg/m2 for day1-12. After XRT, repeat the cycle of 150-200mg/m2 for 5 days and cessation for 23 days.

Timeline

Start date
2009-09-01
Primary completion
2016-02-29
Completion
2016-02-29
First posted
2009-09-11
Last updated
2018-04-25

Locations

1 site across 1 country: Japan

Source: ClinicalTrials.gov record NCT00974987. Inclusion in this directory is not an endorsement.